Dr. Reddy's Laboratories Limited — Investor Meet, 09-07-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Dr. Reddy's will hold a conference call to discuss issues with certain batches of semaglutide. The product was found out of specification due to an API problem, delaying commercial supplies. The company confirms no impact on patient safety or regulatory filings, and will answer questions from participants.